Lemon Healthcare

365660 · KOSDAQ · ₩365660 · 레몬헬스케어

₩4,040▲ ₩450 (12.53%)End-of-day · Oct 26, 2026 · End-of-day prices.
Trade
Alert me

What brokers say about Lemon Healthcare

No public broker reports on this company yet.

Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.

AI summary of public information

An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.

Lemon Healthcare, listed in July 2026, has fallen sharply since listing with no revenue or profit figures in the data provided.

Lemon Healthcare is a KOSDAQ-listed software company that listed on 6 July 2026 and closed at ₩3,590 on 23 October 2026, a market value of about ₩48.3B. The share price is down 17.5% over one month and 28.2% over three months, though it remains well above its 52-week low of ₩2,820. The data contains no income statement figures, and the company profile is missing.

What stands out

  • Balance sheet data is limited: cash of about ₩20.9B against borrowings of ₩1.8B, and liabilities at 47.4% of equity as of H1 2026.
  • Revenue, operating income, net income and free cash flow are not available in the data, so profitability cannot be assessed.
  • Price-to-book is 2.7; price-to-earnings and other earnings-based valuation measures are not available.
  • Institutions were net sellers over the last 20 days (about -₩1.5B), while retail investors were net buyers (about ₩1.5B); foreign ownership rose from 0.7% to 1.6% over 60 days.
  • Filings since listing include a half-year report for June 2026, several 5%+ holding reports, insider shareholding reports and a change of head office location.

What to watch

  • The half-year 2026 report filed in August is the latest full financial disclosure in the data; check it for revenue and profit detail.
  • Further 5%+ holding or insider shareholding filings, which could signal changes in major shareholdings.
  • Share price volatility since listing, given the 52-week range of ₩2,820 to ₩20,300.

Data as of Oct 23, 2026 · written 4d ago

This is not financial advice.

Also known as: Lemon Healthcare / 레몬헬스케어 / 365660 / KRX:365660

Source: KRX statistical information